![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
UBM India, India’s leading B2B exhibition organizer, is all set to bring in the second edition of the widely appreciated India Pharma Week, a week-long celebration packed with avant-garde events from 25th to 30th November alongside its flagship expo CPhI and P-MEC India.
In its 11th edition, the marquee expo will be held at two venues in Mumbai – MMRDA Grounds, Bandra Kurla Complex (27th to 29th November) and Bombay Exhibition Centre (28th to 30th November).
Celebrating 11 years of CPhI and P-MEC India, the India Pharma Week will organise more than 10 events and activities taking place across the city of Mumbai pertaining to the streams of business, knowledge, leadership, innovation, recognition and networking in the field of Pharma.
Speaking on the announcement of the IPW, Mr. Yogesh Mudras, Managing Director, UBM India said, “I am delighted to announce the second edition of the India Pharma Week, an unrivalled offering to the world of exhibitions along with CPhI & P-MEC India, UBM’s flagship engagement platform, and the world’s leading Pharmaceutical networking event. An epitome of India’s strength in the Pharma industry, the expo has consistently grown to serve as an exclusive congregation of key global players across the pharmaceutical sector. Further, the expo would deliberate upon Government of India’s ‘Pharma Vision 2020′ to make India a global leader in end-to-end drug manufacturing in boosting investments.
“The India Pharma Week stems from the proactive role it plays in driving key Governmental initiatives such as ‘Make in India’, ‘Start-Up India, Stand Up India’, and ‘Skill India’ connecting the global community to eke out solutions to challenges, and establishing superior standards within it. With the recent proposal by the Drug Controller General of India (DCGI) to make it mandatory for all employees in pharmaceutical manufacturing facilities to get skill certification, a notable congregation of industry experts and knowledge sharing, such as IPW provides becomes even more significant,” he further added.
The week will commence with a Plant visit followed by a series of engagements such as Pharma Leaders Golf, Pre-Connect Congress, Women in Pharma – Power Breakfast, India Pharma Awards, Networking Evening, the CPhI & P-MEC India Exhibition, a closed-door CEO Roundtable and many more activities.
CPHI provides global platform for the Indian Pharma industry to know and have the exposure of the latest technology available. In the past, Indian Pharmaceutical decision makers had to travel to international exhibitions to get to know new innovations on the technology front, however CPHI & P-Mec has brought this information to Indian pharma’s doorsteps”, said Mr. Damanjit Singh, CEO, Food & Pharma Specialities.
Ms. Saloni Wagh, Marketing & Business Development – Asia Pacific, Supriya Lifescience also shared her past experiences of the CPhI conference and said, “CPhI is one of the leading Pharma events in the world where the entire Industry comes together to discuss and get updated on the current trends, information and issues. CPhI Worldwide exhibitions do play an important role in our marketing strategy as it is a platform for us to meet all our customers from across the globe under one roof. It is also a great platform to launch new products and to identify potential customers, she further added.”
Incepted in 2006, the CPhI & P-MEC India exhibition has grown remarkably larger over the years with exhibitors and visitors engaging over significant levels of business. It has been approved and comprehensively assisted in its endeavours by governing bodies such as Pharmaceuticals Export Promotion Council (Pharmexcil). Spread across two locations, this year’s edition will see more than 1500 exhibitors and participation from over 40 countries.
About the CPhi-PMEC expo:
Originating from CPhI Worldwide – CPhI India has become South Asia’s leading Pharma meeting place covering every step of the supply chain from drug discovery to finished dosage, encompassing CROs, CMOs and manufacturers of API, Generics, Excipients and Drug formulation, Fine chemicals, Biosimilars, Finished Formulations, Lab chemicals and Biotechnology.
P-MEC, on the other hand, includes manufacturers of Pharma Machinery and Equipment, Analytical Equipment, Automation & Robotics, Packaging Equipment & Supplies, Plant / Facility Equipment, Automation & Controls, Processing Equipment, RFID, Tableting / Capsule fillers, Clean room equipment, Filling equipment and Laboratory products.
About UBM India:
UBM India is India’s leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences and seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit ubmindia.in.
